Genmab A/S Files 6-K, Incorporates Exhibit 99.1
Ticker: GNMSF · Form: 6-K · Filed: Nov 6, 2024 · CIK: 1434265
| Field | Detail |
|---|---|
| Company | Genmab A/S (GNMSF) |
| Form Type | 6-K |
| Filed Date | Nov 6, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, 6-k, registration
TL;DR
Genmab 6-K filed: Exhibit 99.1 linked to S-8 filings.
AI Summary
Genmab A/S filed a Form 6-K on November 6, 2024, to report information for the month of November 2024. Exhibit 99.1 of this filing is incorporated by reference into Genmab A/S's existing registration statements on Form S-8, specifically those with file numbers 333-232693, 333-253519, 333-262970, and 333-277273.
Why It Matters
This filing indicates that Genmab A/S is providing updated information to the SEC, and a specific exhibit is being referenced in their ongoing stock registration statements.
Risk Assessment
Risk Level: low — This is a routine filing by a foreign private issuer to update or provide information, with no immediate financial or operational impact indicated.
Key Players & Entities
- Genmab A/S (company) — Registrant
- 0001558370-24-014552 (filing_id) — Accession Number
- 20241106 (date) — Filing Date
- Form 6-K (document_type) — Filing Type
- Form S-8 (document_type) — Incorporated Registration Statement
- 333-232693 (registration_number) — Form S-8 File Number
- 333-253519 (registration_number) — Form S-8 File Number
- 333-262970 (registration_number) — Form S-8 File Number
- 333-277273 (registration_number) — Form S-8 File Number
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is a report of foreign private issuers pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934, used to furnish information which the issuer publishes, is required to publish, or is required to file with any stock exchange on which it has securities listed.
What does it mean for Exhibit 99.1 to be 'incorporated by reference'?
When a document is incorporated by reference, it means that the SEC filing is treated as if the content of the referenced document is physically included within the current filing, making it part of the official record.
What are the Form S-8 registration statements used for?
Form S-8 is used by companies to register securities that are to be offered to employees pursuant to employee benefit plans.
What is the filing date of this Form 6-K?
The filing date of this Form 6-K is November 6, 2024.
Where is Genmab A/S's principal executive office located?
Genmab A/S's principal executive office is located at Carl Jacobsens Vej 30, 2500 Valby, Denmark.
Filing Stats: 199 words · 1 min read · ~1 pages · Grade level 12.9 · Accepted 2024-11-06 11:11:00
Filing Documents
- gmab-20241106x6k.htm (6-K) — 22KB
- gmab-20241106xex99d1.htm (EX-99.1) — 1442KB
- gmab-20241106xex99d1002.jpg (GRAPHIC) — 5KB
- gmab-20241106xex99d1005.jpg (GRAPHIC) — 103KB
- gmab-20241106xex99d1006.jpg (GRAPHIC) — 80KB
- gmab-20241106xex99d1007.jpg (GRAPHIC) — 2KB
- gmab-20241106xex99d1008.jpg (GRAPHIC) — 4KB
- gmab-20241106xex99d1009.jpg (GRAPHIC) — 2KB
- gmab-20241106xex99d1010.jpg (GRAPHIC) — 2KB
- gmab-20241106xex99d1011.jpg (GRAPHIC) — 3KB
- gmab-20241106xex99d1012.jpg (GRAPHIC) — 2KB
- gmab-20241106xex99d1013.jpg (GRAPHIC) — 3KB
- gmab-20241106xex99d1014.jpg (GRAPHIC) — 3KB
- gmab-20241106xex99d1015.jpg (GRAPHIC) — 2KB
- gmab-20241106xex99d1016.jpg (GRAPHIC) — 3KB
- gmab-20241106xex99d1017.jpg (GRAPHIC) — 1KB
- 0001558370-24-014552.txt ( ) — 1766KB
From the Filing
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE MONTH OF NOVEMBER 2024 COMMISSION FILE NUMBER 001-38976 Genmab A/S (Exact name of Registrant as specified in its charter) Carl Jacobsens Vej 30 2500 Valby Denmark +45 70 20 27 28 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F. Form 20-F Form 40-F Exhibit 99.1 to this report on Form 6-K shall be deemed to be incorporated by reference in Genmab A/S's registration statement on Form S-8 (File No. 333-232693, 333-253519, 333-262970 and 333-277273 ) and in the outstanding prospectus contained in such registration statement. SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. GENMAB A/S BY: /s/ Anthony Pagano Name: Anthony Pagano Title: Executive Vice President & Chief Financial Officer DATE: NOVEMBER 6, 2024 EXHIBIT INDEX A Exhibit Description of Exhibit 99.1 Interim Report Dated November 6, 2024